Investing Profile

Hongbo Lu

InvestorVC
Managing Partner at Vivo Capital
Photo of Hongbo Lu, Partner at Vivo Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Vivo Capital Partner
$10.0M - $50.0M
$25.0M
9
$1.4B
CompanyStageDateRound SizeTotal Raised
Rgenta Therapeutics
Series ANov 2022$52M
SeedMay 2021$18M
$90M
Co-investors: Fei Shen (Boehringer Ingelheim Venture Fund), Martin Heidecker (AMR Action Fund)
Zenas BioPharma
Series BNov 2022$120M
$120M
Visirna Therapeutics
SeedApr 2022$60M
$60M
Co-investors: Gaurav Aggarwal (Vivo Capital)
Avistone Pharmaceuticals
Series ADec 2021$200M
$200M
Ablaze Pharmaceuticals
Series ANov 2021$75M
$75M
Co-investors: Aaron Royston (venBio)
Avedro
Series FMay 2018$25M
Series ENov 2015$32M
$150M
Co-investors: Doug Cole (Flagship Ventures), Phil Ferneau (Borealis Ventures), David Berry (Flagship Ventures), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest)
Turning Point Therapeutics
Series CMay 2017$45M
$130M
Co-investors: Carl Gordon (OrbiMed), Simeon J. George (SR One)